Taxanes for adjuvant treatment of early breast cancer von Ferguson, T, Wilcken, N, Vagg, R, Ghersi, D, Nowak, A K

Volltext

A systematic review of taxane-containing regimens for metastatic breast cancer von GHERSI, D, WILCKEN, N, SIMES, R. J

Volltext

Third consensus on medical treatment of metastatic breast cancer von Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmauer, E., Stockler, M., Van Belle, S., Vogel, C., Wilcken, N., Wiltschke, C., Zielinski, C. C., Zwierzina, H.

Volltext

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype von Gurney, H, Wong, M, Balleine, R L, Rivory, L P, McLachlan, A J, Hoskins, J M, Wilcken, N, Clarke, C L, Mann, G J, Collins, M, Delforce, S‐E, Lynch, K, Schran, H

Volltext

Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study von Cameron, B., Webber, K., Li, H., Bennett, B.K., Boyle, F., de Souza, P., Wilcken, N., Lynch, J., Friedlander, M., Goldstein, D., Lloyd, A.R.

Volltext

1535 Estimating scenarios for survival time in patients with HER2 positive, metastatic breast cancer starting HER2 targeted therapies von Vasista, A, Stockler, M, West, T, Wilcken, N, Kiely, B

Volltext

More than just the median: Calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials von Vasista, A, Stockler, M.R, West, T, Wilcken, N, Kiely, B.E

Volltext

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer von Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N., Jefford, M.

Volltext

Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer von Stockler, M., Wilcken, N.R.C., Ghersi, D., Simes, R.John

Volltext

Single agent versus combination chemotherapy for metastatic breast cancer von Carrick, S, Parker, S, Wilcken, N, Ghersi, D, Marzo, M, Simes, J

Volltext

Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer von Nowak, AK, Wilcken, NRC, Stockler, MR, Hamilton, A, Ghersi, D

Volltext

Taxane containing regimens for metastatic breast cancer von Ghersi, D, Wilcken, N, Simes, J, Donoghue, E

Volltext

Post-cancer fatigue is not associated with immune activation or altered cytokine production von Cameron, B.A., Bennett, B., Li, H., Boyle, F., deSouza, P., Wilcken, N., Friedlander, M., Goldstein, D., Lloyd, A.R.

Volltext

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? von Duric, V. M., Stockler, M. R., Heritier, S., Boyle, F., Beith, J., Sullivan, A., Wilcken, N., Coates, A. S., Simes, R. J.

Volltext

Retrospective imaging audit and cost analysis of medical oncology inpatients admitted to Westmead Hospital von Gupta, S., Taylor, N., Selvakumar, D., Harnett, P. R., Wilcken, N., Lee, C. I.

Volltext

Second consensus on medical treatment of metastatic breast cancer von Beslija, S., Bonneterre, J., Burstein, H., Cocquyt, V., Gnant, M., Goodwin, P., Heinemann, V., Jassem, J., Köstler, W.J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmauer, E., Stockler, M., Van Belle, S., Vogel, C., Wilcken, N., Wiltschke, C., Zielinski, C.C., Zwierzina, H.

Volltext

Addition of drug/s to a chemotherapy regimen for metastatic breast cancer von Jones, D, Ghersi, D, Wilcken, N

Volltext

Platinum containing regimens for metastatic breast cancer von Carrick, S, Ghersi, D, Wilcken, N, Simes, J

Volltext

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years von Pan, Hongchao, Gray, Richard, Braybrooke, Jeremy, Davies, Christina, Taylor, Carolyn, McGale, Paul, Peto, Richard, Pritchard, Kathleen I, Bergh, Jonas, Dowsett, Mitch, Hayes, Daniel F

Volltext

Neoadjuvant chemotherapy with sequential anthracycline–docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem) von McCarthy, N, Boyle, F, Zdenkowski, N, Bull, J, Leong, E, Simpson, A, Kannourakis, G, Francis, P.A, Chirgwin, J, Abdi, E, Gebski, V, Veillard, A.S, Zannino, D, Wilcken, N, Reaby, L, Lindsay, D.F, Badger, H.D, Forbes, J.F

Volltext